Batavia Biosciences and Valneva collaborated to accelerate development of low-cost inactivated polio vaccine
On Jun. 15, 2020, Batavia Biosciences and Valneva announced a collaboration agreement to accelerate market-access of a low-cost…
On Jun. 15, 2020, Batavia Biosciences and Valneva announced a collaboration agreement to accelerate market-access of a low-cost…
On Jun. 15, 2020, Catalent announced that it will provide vial filling and packaging capacity to AstraZeneca at…
On Jun. 13, 2020, AstraZeneca announced it had reached an agreement with Europe’s Inclusive Vaccines Alliance (IVA), spearheaded…
On Jun. 13, 2020, Sinovac Biotech announced positive preliminary results of phase I/II clinical trial for the Company’s…
On Jun. 12, 2020, the Food and Drug Administration (FDA) announced it had approved an expanded indication for…
On Jun. 11, 2020, Sinovac Biotech announced the signing of a clinical development collaboration agreement to advance the…
On Jun. 11, 2020, Emergent BioSolutions announced deployment of its molecule-to-market contract development and manufacturing (CDMO) services to…
On Jun. 11, 2020, Moderna announced progress on late-stage development of mRNA-1273, the Company’s mRNA vaccine candidate against…
On Jun. 10, 2020, researchers at Washington University School of Medicine in St. Louis reported they have developed…
On Jun. 10, 2020, Johnson & Johnson announced that through its Janssen Pharmaceutical subsidiary it has accelerated the…
On Jun. 10, 2020, Catalent announced that it had signed an agreement with Spicona to develop a virus-like…
On Jun. 8, 2020, Intravacc and Versatope announced that they have signed a research service agreement to further…
On Jun. 5, 2020, CEPI, the Coalition for Epidemic Preparedness Innovations, CSL and The University of Queensland (UQ)…
On Jun. 5, 2020, the Alberta Precision Laboratories (APL) COVID-19 Biorepository was announced to ensure researchers have the…
On Jun. 4, 2020, the World Health Organization (WHO) welcomed funding commitments from Gavi, the Vaccine Alliance’s third…
On Jun. 4, 2020, AstraZeneca announced the next steps in its commitment to broad and equitable global access…
On Jun. 4, 2020, Novavax announced that the company had been awarded a contract by the U.S. Department…
On Jun. 4, 2020, INOVIO and Seoul National University Hospital announced a partnership to start a Phase 1/2…
On Jun. 4, 2020, iBio announced initiation of preclinical immunization studies for its second COVID-19 vaccine platform. The…
On Jun. 4, 2020, world leaders pledged an additional US$ 8.8 billion for Gavi, the Vaccine Alliance, far…
On Jun. 4, 2020, the Bill & Melinda Gates Foundation announced a five-year, US$1.6 billion commitment to Gavi,…
On Jun. 4, 2020, the United Kingdom (UK) helped secure $7.4 billion in funding to support global vaccine…
On Jun. 3, 2020, CEPI, the Coalition for Epidemic Preparedness Innovations, in collaboration with Ind-CEPI, announced a new…
On Jun. 3, 2020, vaccine manufacturers MSD, GSK, Innovax, Serum Institute of India (SII) and Walvax have pledged…
On Jun. 1, 2020,The Government of the Democratic Republic of the Congo announced that a new outbreak of…
On Jun. 1, 2020, Emergent BioSolutions announced it had been issued a task order under an existing contract…
On Jun. 1, 2020, Tonix Pharmaceuticals announced an agreement whereby FUJIFILM Diosynth Biotechnologies will provide contract manufacturing and…
On May 31, 2020, Cytiva announced their Fast Trak process development team will use their expertise to develop…
On May 29, 2020, the World Health Organization (WHO) announced that thirty countries and multiple international partners and…
On May 29, 2020, Moderna announced the first participants in each age cohort had been dosed in the…